An FDA perspective on preclinical development of cell-based regenerative medicine products
Crossref DOI link: https://doi.org/10.1038/nbt.2971
Published Online: 2014-08-05
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bailey, Alexander M
Mendicino, Michael
Au, Patrick
Text and Data Mining valid from 2014-08-01
Article History
First Online: 5 August 2014
Competing interests
: The authors declare no competing financial interests.